Free access
Research Article
1 March 2000

Clinical Application of a Dot Blot Test for Diagnosis of Enteric Fever Due to Salmonella entericaSerovar Typhi in Patients with Typhoid Fever from Colombia and Peru

ABSTRACT

Clinical application of a dot blot test to detect immunoglobulin G (IgG) (88% sensitivity and specificity) and IgM (12.1% sensitivity and 97% specificity) against flagellar antigen from Salmonella enterica serovar Typhi was performed in Peruvian and Colombian patients with typhoid fever. This test can be used as a good predictor of serovar Typhi infection in regions lacking laboratory facilities and in field studies.
One hundred and two volunteers older than 15 years with typhoid fever confirmed by bacteriological isolation of Salmonella enterica serovar Typhi from blood culture were included in this study. They were treated at the Instituto Colombiano de Medicina Tropical (ICMT) (Medellı́n and Apartadó, Colombia) or Hospital Cayetano Heredia (Lima, Perú) in 1997 and 1998. When typhoid fever was suspected, blood samples were collected for triplicate cultures (7, 8, 11, 17), and one serum sample was collected for dot blot analysis. Once diagnosis of typhoid fever was confirmed by bacteriological isolation, patients were included in the study and were dot blot tested on days 1, 7, and 15.
Serovar Typhi 1991-ICMT (isolated from the blood of a patient at the ICMT) was used to obtain the flagellar antigen. Antigen isolation and purification was carried out following procedures previously described (10). Briefly, a colony obtained from a 37°C overnight culture in nutritive agar was subcultured into 400 ml of brain heart infusion broth (Becton Dickinson BBL) at 37°C for 16 h. Bacteria were centrifuged at 500 × g for 30 min, the pellet was resuspended in 150 ml of saline, and pH was adjusted to 2. The suspension was centrifuged at 3,000 × g for 30 min, the supernatant was recovered, and the insoluble material was isolated by centrifugation at 40,000 × g for 1 h at 4°C. Two volumes of ammonium sulfate (2.67 M) were added to the recovered supernatant (pH 7.2), and the solution was stored at 4°C overnight. Polymerized flagellar protein was then recovered from the pellet after 15 min of centrifugation at 15,000 × g at 4°C, was dissolved in 5 ml of distilled water, and was dialyzed with a 50,000-pm-pore-size filter into distilled water for 2 h at room temperature and then for 18 h at 4°C into 500 ml of distilled water containing 20 g of activated carbon. Purified antigen was stored at −70°C. Antigen protein concentration was 0.7 mg/ml as determined by the Lowry method (14). Antigen purity was checked in a 10% polyacrylamide gel, and the purified flagellar protein mass was determined to be 45 to 66 kDa (10). Dot blot analysis was carried out by using nitrocellulose paper (1, 5; Bio Dot microfiltration apparatus instruction manual, Bio-Rad Laboratories, Richmond, Calif.). The paper was first soaked with Tris- buffered saline (TBS), then the membrane was placed into a Bio Dot microfiltration apparatus (Bio-Rad Laboratories). The membrane was rehydrated by using 100 μl of phosphate-buffered saline per well, which was later vacuum extracted. This was followed by the fixation of 100 μl (5 μg/ml) of flagellar antigen to each well (14; Bio Dot instruction manual, Bio-Rad). Blocking solution, fetal calf serum, and 1% TBS were added (200 μl per well) and left to gravity filter. The membrane was vacuum washed with a solution of Tween and TBS. Serum samples were added in 1:50, 1:100, and 1:200 dilutions and were left to filter by gravity.
Each membrane had six serum blank wells in order to detect any unspecific color and positive and negative controls in 1:50, 1:100, and 1:200 dilutions (1, 14). After Tween-TBS washing, 100 μl of goat anti-human immunoglobulin G (IgG) or IgM (Jackson Immuno Research Laboratories) was added and gravity filtered. Finally, 4-chloronaphthol (Sigma Chemicals Co.) was added for 20 min to develop the reaction. The membrane was washed with distilled water to stop the reaction. The membrane was allowed to dry prior to the final color visualization reading (1, 14; Bio Dot instruction manual, Bio-Rad).
A total of 102 patients with typhoid fever were studied: 48 Colombians and 54 Peruvians. Difficulties arose in monitoring outpatients who had been released 7 days before the second control was scheduled. Table1 summarizes the number of patient samples studied.
Table 1.
Table 1. Number of samples tested from typhoid fever patients
Country of sample originNo. of samples tested on:Total
Day 1Days 1 and 7Days 1, 7, and 15Day 15
Colombia3864 48
Peru3178854
Total6913128102
Percentages of patients with typhoid fever positive for IgG and IgM against the flagellar antigen of serovar Typhi on the day of evaluation are shown in Table 2.
Table 2.
Table 2. Number of patients with positive antibody titers (range, 1:100 to 1:200) at three periods of evaluation
No. of patients testing positive ona:
Day 1Days 1 and 7Days 1, 7, and 15Day 15
IgGIgMIgGIgMIgGIgMIgGIgM
66/6969/6910/1414/1410/1212/126/87/8
a
Given as number testing positive per total number tested.
On the first day of evaluation, 69 patients were tested: all of them were IgM positive and 66 had titers for IgG. Twelve patients had three serum controls (days 1, 7, and 15): 11 patients were IgM positive at the three time points tested and one patient was positive only in one. Seven patients were positive for IgG in all the periods, and three were positive in at least one. Fourteen patients were evaluated on the 1st and 7th days, and all of them were positive for IgM at both time points and 10 were IgG positive at both time points. Eight patients were evaluated on the 15th day only: seven were IgM positive and six were IgG positive.
The ideal test for an early diagnosis of typhoid fever must be sensitive, specific, rapid, simple, and inexpensive. However, conventional laboratory tests based on cultures of serovar Typhi from blood, bone marrow, feces, and urine and the Widal test lack these characteristics (2, 9, 16).
The development of a diagnostic test, a dot blot to detect IgG and IgM against flagellar antigen of Serovar Typhi, with a sensitivity and specificity of 88% for IgG detection and a sensitivity of 12.1% and 97% of specificity to detect IgM (1) was obtained. The dot blot test can be a diagnostic alternative in detecting typhoid fever, is an easy-to-read visual test, does not require complex laboratory facilities or training, and would be useful in rural areas where microbiology laboratory resources are difficult to obtain or are unavailable (1, 6, 16). This test can be used for the detection of IgG and IgM antibodies against serovar Typhi flagellar antigen at any of the evaluated time points during the course of typhoid fever (days 1, 7, and 15).
Serology and longevity of antibody response to several antigens from serovar Typhi had been evaluated (3, 4, 12, 13, 15). Choo et al. (4) found that the average persistence was 2.6 months, and the IgG persisted, on average, for 5.4 months. These results indicated the presence of IgG and IgM from the 1st to the 15th day of the study.
The dot blot test to detect IgG and/or IgM against flagellar antigen of serovar Typhi can be used in laboratories in rural areas of developing countries where typhoid fever is endemic, as these regions lack the necessary facilities for isolation of bacteria. This test can also be used in field research.

Acknowledgments

This work was supported by Colciencias grant 3256-04-304-98 from Colombia, Instituto Colombiano de Medicina Tropical (Medellı́n, Colombia), and Instituto de Medicina Tropical Alexander Von Humbolt—Hospital Cayetano Heredia (Lima, Perú).

REFERENCES

1.
Cardona-Castro N. and Agudelo-Flórez P. Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area Clin. Microb. Infect. 2 1998 64 -69
2.
Chaky R. B. and Blaser M. J. A review of human salmonellosis. III. Magnitude of Salmonella infection in the United States Rev. Infect. Dis. 10 1988 111 -124
3.
Chart H., Rowe B., and Cheesbrough J. S. Serological response of patients infected with Salmonella typhi J. Clin. Pathol. 11 1997 944 -946
4.
Choo K. E., Davis T. M., Ismail A., and Ong K. H. Longevity of antibody responses to a Salmonella typhi-specific outer membrane protein: interpretation of a dot enzyme immunosorbent assay in an area of high typhoid fever endemicity Am. J. Trop. Med. Hyg. 6 1997 656 -659
5.
Choo K. E., Oppenheimer S. J., Asma B. I., and Ong K. H. Rapid serodiagnosis of typhoid fever by dot enzyme immunoassay in an endemic area Clin. Infect. Dis. 19 1994 172 -176
6.
Edelman R. and Levine M. M. Summary of an international workshop on typhoid fever Rev. Infect. Dis. 8 1986 329 -349
7.
Guerra-Cáceres J. G., Gotuzzo-Heredia E., and Crosby-Dagninol E. Diagnostic value of bone marrow culture in typhoid fever Trans. R. Soc. Trop. Med. Hyg. 73 1979 680 -683
8.
Hoffman S. L., Punjabi N. H., and Rockhill R. C. Duodenal string-capsule culture compared with bone marrow, blood and rectal swab cultures for diagnosing typhoid and paratyphoid fever J. Infect. Dis. 149 1984 157 -161
9.
Hook E. W. Salmonella species (including typhoid fever) Principles and practice of infectious diseases. Mandel G. L., Douglas R. G., and Bennet J. E. 1990 1256 -1269 John Wiley & Sons New York, N.Y
10.
Ibrahim G. F., Fleet G. H., Lyons M. L., and Walker R. A. Method for the isolation of highly purified Salmonella flagellins J. Clin. Microbiol. 22 1985 1040 -1044
11.
Isenberg H. D., Washington J. A. II, Balows A., and Sonnenwirth A. C. Collection, handling and processing of specimens Manual of clinical microbiology 4th ed. Lennette E. H., Balows A., Hausler W. J. Jr., and Shadomy H. J. 1985 73 American Society for Microbiology Washington, D.C.
12.
Isomaki O., Vuento R., and Granfors K. Serological diagnosis of Salmonella infections by enzyme immunoassay Lancet ii 1989 1411 -1414
13.
Jesudasun M. V., Sridharan G., Aruselvan R., Babu P. G., and John T. J. Diagnosis of typhoid fever by the detection of anti LPS & anti-flagellin antibodies by ELISA Indian J. Med. Res. 107 1998 204 -207
14.
Lane D. Antibodies: a laboratory manual. 1988 Cold Spring Harbor Laboratory Cold Spring Harbor, N.Y
15.
Nardiello S., Pizzela T., Russo M., and Galanti B. ELISA determination of IgM anti-LPS in the early phase of typhoid fever Boll. Ist. Sieroter. Milan. 62 1983 372 -375
16.
Prada G. Tifoidea, flagelo del Tercer Mundo Acta Medica Colombiana 15 1990 125 -130
17.
Vallenas C., Hernandez H., Kay B., Black R., and Gotuzzo E. Efficacy of bone marrow, blood, stool and duodenal contents culture for bacteriologic confirmation of typhoid fever in children Pediatr. Infect. Dis. 5 1985 496 -498

Information & Contributors

Information

Published In

cover image Clinical Diagnostic Laboratory Immunology
Clinical Diagnostic Laboratory Immunology
Volume 7Number 21 March 2000
Pages: 312 - 313
PubMed: 10702512

History

Received: 27 September 1999
Returned for modification: 5 November 1999
Accepted: 21 December 1999
Published online: 1 March 2000

Permissions

Request permissions for this article.

Contributors

Authors

Nora Cardona-Castro
Instituto Columbiano de Medicina Tropical, AA 52162 Medellı́n, Colombia,1 and
Eduardo Gotuzzo
Hospital Cayetano Heredia—Instituto de Medicina Tropical Alexander von Humbolt, Lima 100, Perú2
Monica Rodriguez
Instituto Columbiano de Medicina Tropical, AA 52162 Medellı́n, Colombia,1 and
Humberto Guerra
Hospital Cayetano Heredia—Instituto de Medicina Tropical Alexander von Humbolt, Lima 100, Perú2

Metrics & Citations

Metrics

Note: There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.

Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy